Home Alemtuzumab Group Members Research For People with MS Contact News
© Website designed by Alasdair Coles, 2012
Alasdair Coles Professor of Neuroimmunology, University of Cambirdge. MRC Training Fellowship 1994-8; Wellcome Advanced Clinical Fellowship 2000-4; University Lecturer in Clinical Neuroimmunology and consultant neurologist since 2004. Medical Advisor to the MS Society. Ordained priest in the Church of England in 2009. PhD 1998; FRCP 2008
YOUR HEADING TEXT Alasdair Coles, Joanne Jones and Alastair Compston Cambridge Neuroimmunology

Investigator Profiles

Alastair Compston Professor Of Neurology at the Univ of Cambridge  since 1989. Head Dept of Clinical Neurosciences from 2004-. Chairman of the MRC Cambridge Centre for Brain Repair 1990-2000. Editor of the Journal of Neurology 1989-99 and of Brain since 2004- President of the Association for British Neurologists 2009-11.  Medical Advisor to the MS Society. FRCP 1986, FRSA 1997, FMedSci 1998, FIBiol 2000.
Joanne Jones Wellcome - Beit Fellow, University of Cambridge and Honorary Consultant Neurologist. Discovered the role of IL-21 in autoimmunity in alemtuzumab and devised the CAM-THY trial. PhD 2005